US Broker Ratings

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Unveiling a 199% Upside Potential in the Biotech Sector

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing the attention of investors with its significant upside potential in the biotech industry. This Watertown, Massachusetts-based company, with a..

Weave Communications, Inc. (WEAV) Investor Outlook: Analyzing a 76.4% Potential Upside

Weave Communications, Inc. (NYSE: WEAV) may not yet be a household name, but its innovative approach to health information services is gaining traction among investors seeking..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a 61.91% Potential Upside

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a Boston-based clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating central nervous..

Bioventus Inc. (BVS) Stock Analysis: Unpacking a 110.73% Potential Upside

Investors with an eye on the healthcare sector might find Bioventus Inc. (NASDAQ: BVS) an intriguing prospect. The company, which specializes in medical devices aimed at..

InnovAge Holding Corp. (INNV) Stock Analysis: A Cautious Investor Outlook Amid Modest Growth

InnovAge Holding Corp. (NASDAQ: INNV) operates within the healthcare sector, specifically focusing on medical care facilities. The company is well-known for its Program of All-Inclusive Care..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Growth Amidst a 7.25% Potential Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, has carved out a niche in the diagnostics and research industry. With a market..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a 29.28% Potential Upside in the Biotech Sector

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), headquartered in Cambridge, Massachusetts, is a clinical-stage biotechnology company dedicated to pioneering treatments for neurodegenerative and endocrine disorders. With a current..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Promising 403% Upside in the Biotechnology Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL) stands as a compelling prospect in the biotechnology sector, with a market capitalization of $750.71 million. The company, headquartered in..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A 37% Potential Upside Beckons Investors in a High-Stakes Biotech Play

Zenas BioPharma, Inc. (NASDAQ: ZBIO) stands as a compelling opportunity in the healthcare sector, particularly for investors with a penchant for high-growth biotech ventures. With a..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a Bold 150% Potential Upside in Biotech

COMPASS Pathways Plc (CMPS) emerges as a fascinating player in the healthcare sector, particularly in the medical care facilities industry. This UK-based biotechnology company is actively..

Replimune Group, Inc. (REPL) Stock Analysis: Evaluating the Biotech’s 23.85% Potential Upside

Replimune Group, Inc. (NASDAQ: REPL) is drawing attention in the healthcare sector, particularly within the biotechnology industry, due to its unique approach to cancer treatment. With..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring Growth Potential and a 12.14% Upside

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry. Headquartered in Dallas, Texas, Enhabit is renowned for..

Orthofix Medical Inc. (OFIX) Stock Analysis: Unlocking a Potential 42.8% Upside for Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors eyeing significant..

Geron Corporation (GERN) Stock Analysis: Exploring a Potential 197% Upside in Biotech

For individual investors with an eye on the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents an intriguing opportunity. With a market capitalization of $778.38 million, this..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring the 197.96% Potential Upside

As the healthcare sector continues to be a focal point for investors, Vir Biotechnology, Inc. (NASDAQ: VIR) stands out with a remarkable potential upside of 197.96%...

KalVista Pharmaceuticals (KALV) Stock Analysis: A Biotech Gem with 179.80% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a promising player in the biotechnology sector, has caught the attention of investors with its significant potential upside of 179.80%. Based..

Inventiva S.A. (IVA) Stock Analysis: A Promising Biotech with 170% Upside Potential

Inventiva S.A. (NASDAQ: IVA), a clinical-stage biopharmaceutical company headquartered in Daix, France, is making waves in the biotechnology sector with its innovative approach to treating metabolic..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A 63% Potential Upside Beckons Investors

AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, is capturing significant attention with its innovative approach to developing antibody-based medicines. Headquartered in..

AnaptysBio, Inc. (ANAB) Stock Analysis: Significant 82.62% Upside Potential for Investors

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, has captured investors’ attention with its impressive potential upside of 82.62%, according to..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds